Physician profile
Malcolm E Andry
NPI 1093776064
$238.62
in general payments reported to CMS, 2019-2025
7 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.10 · 2022: $15.13 · 2023: $27.97 · 2024: $35.47 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $68.52 | 2021-2023 | Creon, Linzess |
| Boston Scientific Corporation | $44.90 | 2023-2025 | Resolution Clip, Hydra Jagwire, Resolution 360 Clip |
| Phathom Pharmaceuticals, INC. | $39.50 | 2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $26.10 | 2025 | Entyvio |
| Aimmune Therapeutics, INC. | $22.04 | 2025 | Zenpep |
| Sanofi Pasteur INC. | $20.03 | 2024 | |
| Janssen Biotech, INC. | $17.53 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malcolm Andry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.